🇺🇸 FDA
Patent

US 7842819

Derivatives for modulation of ion channels

granted A61PA61P1/00A61P19/02

Quick answer

US patent 7842819 (Derivatives for modulation of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P1/00, A61P19/02, A61P21/00, A61P25/00